Efforts towards the optimization of a bi-aryl class of potent IRAK4 inhibitors
Journal Article
·
· Bioorganic and Medicinal Chemistry Letters
IRAK4 has been identified as potential therapeutic target for inflammatory and autoimmune diseases. Herein we report the identification and initial SAR studies of a new class of pyrazole containing IRAK4 inhibitors designed to expand chemical diversity and improve off target activity of a previously identified series. These compounds maintain potent IRAK4 activity and desirable ligand efficiency. Rat clearance and a variety of off target activities were also examined, resulting in encouraging data with tractable SAR.
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- INDUSTRY
- OSTI ID:
- 1404961
- Journal Information:
- Bioorganic and Medicinal Chemistry Letters, Vol. 26, Issue 17; ISSN 0960-894X
- Publisher:
- Elsevier
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation
Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitors
Discovery of 5-Amino- N -(1 H -pyrazol-4-yl)pyrazolo[1,5- a ]pyrimidine-3-carboxamide Inhibitors of IRAK4
Journal Article
·
Thu May 07 00:00:00 EDT 2015
· ACS Medicinal Chemistry Letters
·
OSTI ID:1404961
+15 more
Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitors
Journal Article
·
Wed Nov 01 00:00:00 EDT 2017
· Bioorganic and Medicinal Chemistry Letters
·
OSTI ID:1404961
+9 more
Discovery of 5-Amino- N -(1 H -pyrazol-4-yl)pyrazolo[1,5- a ]pyrimidine-3-carboxamide Inhibitors of IRAK4
Journal Article
·
Thu Jun 11 00:00:00 EDT 2015
· ACS Medicinal Chemistry Letters
·
OSTI ID:1404961
+16 more